"Overview of Induction and Maintenance Immunosuppression"
This lecture will provide an overview of the role of induction and maintenance immunosuppression in kidney and liver transplant patients.
Note: Thymoglobulin is now approved as an induction agent for prevention of rejection.
Use the markers on the video timeline to quickly navigate to important points in the video outlined below: - Chapter 1: Introduction to immunosuppression [0:51] - Section A) Timeline for Development of various Immunosuppressive agents [1:36] - Section B) Targets for Immunosuppressive agents [2:21] - Section C) Type of Immunosuppressive agents [3:25] - Chapter 2: Induction Immunosuppressive agents [4:04] - Chapter 3: Maintenance immunosuppressive agents [14:43] - Section A) Calcineurin Inhibitors [16:28] - Section B) mTor Inhibitors [23:39] - Section C) Co-stimulation Blockade agents (Belatacept) [28:33] - Section D) Anti-Metabolites- Mycophenolate and Azathioprine [31:00] - Section E) Corticosteroids [35:00]
PharmD, FAST, FCCP, BCPS,
Massachusetts General Hospital Transplant Center
You must be logged in and own this session in order to